Firms
Theme

GRMN

Garmin Ltd · NYSE

News

7 latest

Zacks Investment Research

DAKT or GRMN: Which Is the Better Value Stock Right Now?

A comparison of two Electronics - Miscellaneous Products sector stocks reveals that Daktronics (DAKT) presents a better value opportunity than Garmin (GRMN). DAKT has a Zacks Rank of #1 (Strong Buy) with a forward P/E of 14.78 and PEG ratio of 0.59, while GRMN has a Zacks Rank of #3 (Hold) with a forward P/E of 28.82 and PEG ratio of 3.25. DAKT also holds a Value grade of B compared to GRMN's D grade.

Zacks Investment Research

Garmin (GRMN) Laps the Stock Market: Here's Why

Garmin (GRMN) closed at $290.35, up 1.46%, outperforming the S&P 500's 0.28% gain. The company is expected to report earnings on October 28, 2026, with projected EPS of $2.38 (19.6% growth) and revenue of $1.99 billion (12.32% growth). However, the stock trades at a premium valuation with a Forward P/E of 28.4 versus the industry average of 18.81, and holds a Zacks Rank of #3 (Hold).

Zacks Investment Research

Garmin (GRMN) Advances While Market Declines: Some Information for Investors

Garmin stock gained 1.2% to $279.72 while the broader market declined on October 14, 2026. The company is expected to report earnings on October 28 with projected EPS growth of 19.6% and revenue growth of 12.32% year-over-year. However, Garmin trades at a premium valuation with a Forward P/E of 27.43 versus its industry average of 20.04, and carries a Zacks Rank of #3 (Hold).

Zacks Investment Research

Garmin (GRMN) Surpasses Market Returns: Some Facts Worth Knowing

Garmin (GRMN) closed at $285.52, up 1.55%, outperforming the S&P 500's 0.66% gain. The company holds a Zacks Rank #2 (Buy) rating with projected Q3 EPS of $2.38 (up 19.60% YoY) and full-year revenue of $8.09 billion (up 11.7% YoY). However, the stock trades at a Forward P/E of 27.91, significantly above its industry average of 20.65, and a PEG ratio of 3.14 versus the industry average of 1.28, indicating premium valuation despite positive growth expectations.

Zacks Investment Research

Here's Why Garmin (GRMN) Fell More Than Broader Market

Garmin (GRMN) declined 1.3% to $290.23 in the latest session, underperforming the broader market. The company holds a Zacks Rank #2 (Buy) rating with expected Q3 EPS growth of 19.6% and full-year earnings growth of 17.76%. However, the stock trades at a premium valuation with a Forward P/E of 29.19 versus the industry average of 20.44, and a PEG ratio of 3.29 compared to the industry average of 1.38.

Zacks Investment Research

Garmin and M/I Homes have been highlighted as Zacks Bull and Bear of the Day

Garmin Ltd. (GRMN) was named Bull of the Day due to impressive revenue and earnings growth, strong momentum in its Fitness segment (up 32% in H1 2026), and a debt-free balance sheet. M/I Homes (MHO) was named Bear of the Day as the homebuilder faces headwinds from rising mortgage rates above 7% and a cooling housing market, with downward earnings revisions and a Zacks Rank #5 (Strong Sell). Micron Technology (MU) was also analyzed ahead of Q4 earnings, with strong AI-driven demand expected to support continued growth.

Mentions GRMN

GlobeNewswire Inc.

Fitness Tracker Market Accelerates as AI-Enabled Biometric Monitoring Advances Preventive Healthcare

The global fitness tracker market is expected to grow from $71.95 billion in 2025 to $378.82 billion by 2035 at an 18.07% CAGR, driven by AI-enabled biometric monitoring, preventive healthcare adoption, and clinical-grade wearable functionality. The U.S. market alone is projected to reach $105.81 billion by 2035.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $GRMN · 0 threads

Sign in to post on $GRMN

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev